Autologous stem cell transplantation for poor prognosis Hodgkin’s disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group
暂无分享,去创建一个
J. Garcia-conde | J. Maldonado | S. Brunet | F. Hernández-Navarro | J. Rifón | A. Torres | J. Sierra | I. Jarque | E. Conde | J. Moraleda | A. Sureda | M. Fernández | D. Caballero | J. Lahuerta | J. Tomás | J. García-Laraña | D. Carrera | A. Domingo-Albós | M. Callis | E. Bengoechea | A. León | R. Mataix | A. López | M. Morey
[1] J. Gribben,et al. The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas , 1987, Hematological oncology.
[2] B. Osborne,et al. Residual fibrous masses in treated Hodgkin's disease , 1987, Cancer.
[3] M. Tubiana,et al. PROGNOSTIC FACTORS IN HODGKIN'S DISEASE , 1985, The Lancet.
[4] M. Imbert,et al. Early response to chemotherapy as a prognostic factor in Hodgkin's disease , 1983, Cancer.